ANG Lifesciences India Ltd Q4 FY2021-22 net profit soars to Rs. 5.28 crores

ANG Lifesciences India Ltd has reported Standalone financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 96.4932 crores during the period ended March 31, 2022 as compared to Rs. 47.2537 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. 5.2819 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 1.2188 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. 5.19 for the period ended March 31, 2022 as compared to Rs. 1.24 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 96.4932 crs	₹47.2537 crs	104.20%
Net Profit	₹5.2819 crs	₹1.2188 crs	333.37%
EPS	₹5.19	₹1.24	318.55%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 96.4932 crores during the period ended March 31, 2022 as compared to Rs.36.5116 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.5.2819 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.1.5957 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.5.19 for the period ended March 31, 2022 as compared to Rs.2.74 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 96.4932 crs	₹36.5116 crs	164.28%
Net Profit	₹5.2819 crs	₹1.5957 crs	231.01%
EPS	₹5.19	₹2.74	89.42%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.349.6209 crores during the Financial Year ended March 31, 2022 as compared to Rs.155.0216 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.39.7130 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.7.2497 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.38.51 for the Financial Year ended March 31, 2022 as compared to Rs.12.63 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹349.6209 crs	₹155.0216 crs	125.53%
Net Profit	₹39.7130 crs	₹7.2497 crs	447.79%
EPS	₹38.51	₹12.63	204.91%

Shares of ANG Lifesciences India Ltd was last trading in BSE at Rs. 237.35 as compared to the previous close of Rs. 244.50. The total number of shares traded during the day was 11346 in over 426 trades.

The stock hit an intraday high of Rs. 252.75 and intraday low of 233.25. The net turnover during the day was Rs. 2719292.00.

Source : Equity Bulls

Keywords

ANGLifesciencesIndia Q4FY22 FY2022 ResultUpdate